AI for Prostate Cancer

About Invenio Imaging

Invenio Imaging is a private, commercial-stage company pioneering real-time intraoperative histology through its NIO Laser Imaging System, which leverages Stimulated Raman Histology (SRH) technology. The company has commercialized its core hardware system and has begun integrating artificial intelligence, evidenced by its CE-marked NIO Glioma Reveal algorithm for brain tumor surgery in the EU. Invenio targets multiple surgical subspecialties, including neurosurgery, pulmonology, and urology, with the goal of improving surgical decision-making and patient outcomes by providing rapid, on-site tissue analysis without destroying the sample.

Therapeutic Areas

Other Prostate Cancer Drugs